Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P56851 (epididymal)
 11,273 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The effects of estradiol benzoate (E2B) at a dose of 200 micrograms/kg body weight/day for 7 and 15 days were investigated on epididymal sperm parameters and morphology of testis in adult mice. The data revealed a decline in cauda epididymal sperm count and percentage motility with duration of estrogen administration. The decreased sperm motility was correlated with reduced sperm enzymes as evidenced by biochemical and cytochemical studies. The depletion of cauda epididymal sperm population in treated mice was related to inhibition of spermatogenic activity in testis as compared to control. Thus, the estrogen treatment to mice manifests maturational changes in epididymal spermatozoa as a result of androgen deprivation.
 ...
PMID:Estrogen induced effects on mouse testis and epididymal spermatozoa. 284 72

The effects of estradiol benzoate (E2B) at a dose of 50 micrograms/day per rat for 7, 15 and 24 days on some androgenic parameters, viz. organ weights including those of pituitary, succinate dehydrogenase, acid phosphatase, fructose, cholesterol and protein of epididymis, vas deferens, accessory glands and fertility in male rats were investigated. The semen characteristics and standard electron microscopy (SEM) study on sperm morphology of cauda epididymis were also carried out. The results revealed that most of the androgenic parameters were decreased by E2B administration, whereas the accumulation of cholesterol and protein occurred in testis and epididymis due to androgen deprivation to target organs. This deprivation effect also led to a reduction in testicular and cauda epididymal sperm population, loss of motility in the latter and an increase in number of abnormal spermatozoa, thereby manifesting 100% failure in fertility in treated animals. Moreover, these effects were related to the duration of the treatment. Thus, the estradiol benzoate showed androgen antagonistic and antifertility effects in rats.
 ...
PMID:Effect of estradiol benzoate on reproductive organs and fertility in the male rat. 661 37

Male rat adipose tissues contain cytoplasmic estrogen binding sites comparable to those found in females. This bindng is of high affinity (Kd = 1.7 x 10(-10) M) and is estrogen specific. Binding of 17 beta-estradiol was inhibited by radioinert estrogens (17 beta-estradiol and R 2858) but not by other steroids (progesterone, 5 alpha-dihydrotestosterone, and corticosterone). Estrogen binding sites were found in all fat pads studied, but levels were highest in the epididymal pads. Treatment of female rats with 17 beta-estradiol benzoate (E2B) induced cytoplasmic progestin receptors in adipose tissues, but in three separate experiments, E2B treatment (20 microgram/day for 3 days) failed to induce measurable progestin ([3H]R 5020) binding sites in males. E2B treatment reduced lipoprotein lipase (LPL) activity by approximately 75% in epididymal (male) and parametrial (female) fat pads. Concurrent progesterone treatment increased parametrial LPL activity in E2B-treated females, but progesterone had no effect on epididymal fat pad LPL activity in males. These findings are consistent with the hypothesis that in male rats aromatized (estrogenic) metabolites of testosterone may reduce body fat content and alter lipid metabolism by direct actions on adipose tissues.
 ...
PMID:Cytoplasmic estrogen, but not progestin, binding sites in male rat adipose tissues. 742 16